Provided by Tiger Trade Technology Pte. Ltd.

Taysha Gene Therapies, Inc.

5.08
+0.00500.10%
Volume:2.25M
Turnover:11.74M
Market Cap:1.65B
PE:-12.30
High:5.46
Open:5.25
Low:5.05
Close:5.07
52wk High:7.30
52wk Low:2.71
Shares:325.83M
Float Shares:233.00M
Volume Ratio:0.59
T/O Rate:0.97%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4126
EPS(LYR):-0.3409
ROE:-47.05%
ROA:-23.82%
PB:4.27
PE(LYR):-14.89

Loading ...

Taysha Gene Therapies grants 188,000 RSUs to five new employees under inducement plan

Reuters
·
May 02

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
May 02

Taysha Gene Therapies to Release First Quarter 2026 Financial Results and Host Conference Call and Webcast on May 6

GlobeNewswire
·
Apr 29

Taysha Gene Therapies to present new TSHA-102 preclinical data at ASGCT annual meeting

Reuters
·
Apr 28

Taysha Gene Therapies announces annual shareholder meeting

Reuters
·
Apr 22

Unusually active option classes on open April 16th

TIPRANKS
·
Apr 16

U.S. Small Caps Finish Mixed As Taysha Gene Therapies Leads, BRP Lags

Dow Jones
·
Apr 16

Buy Rating on Taysha Gene Therapies Driven by Strong Leadership, Strategic Positioning, and Attractive Risk‑Reward Upside

TIPRANKS
·
Apr 15

Taysha Gene Therapies President Sukumar Nagendran disposes 200,000 shares for $892,000

Reuters
·
Apr 14

Taysha Gene Therapies Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Apr 06

Taysha Gene Therapies price target raised to $17 from $14 at Canaccord

TIPRANKS
·
Apr 06

Taysha grants 300,000 RSUs under Nasdaq inducement plan for new hires

Reuters
·
Apr 03

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Apr 03

Stock Track | Taysha Gene Therapies Soars 5.33% Intraday After Cantor Fitzgerald Issues Buy Rating

Stock Track
·
Mar 25

Taysha Gene Therapies (TSHA) Receives a Buy from Cantor Fitzgerald

TIPRANKS
·
Mar 25

Should Rett Breakthrough Status and Pivotal Trial Progress Require Action From Taysha Gene Therapies (TSHA) Investors?

Simply Wall St.
·
Mar 23

Taysha Gene Therapies (TSHA) Receives a Buy from Wells Fargo

TIPRANKS
·
Mar 22